Trial Profile
Effective Pain Management During Shoulder Replacement Surgery With Either Continuous Ropivacaine Interscalene Nerve Block or Local Infiltration With EXPAREL After Single Shot Injection Ropivacaine Interscalene Nerve Block
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 02 Mar 2021
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary) ; Ropivacaine
- Indications Postoperative pain
- Focus Therapeutic Use
- 24 Feb 2021 Status changed from recruiting to withdrawn prior to enrolment due to Investigator Decision.
- 08 Apr 2019 Planned primary completion date changed from 12 Feb 2019 to 12 May 2019.
- 19 Jul 2018 Status changed from not yet recruiting to recruiting.